On Friday, Kala Bio Inc (NASDAQ: KALA) opened lower -6.64% from the last session, before settling in for the closing price of $0.96. Price fluctuations for KALA have ranged from $0.61 to $20.60 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 40.66%. Company’s average yearly earnings per share was noted 56.16% at the time writing. With a float of $6.04 million, this company’s outstanding shares have now reached $7.43 million.
Kala Bio Inc (KALA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Kala Bio Inc is 3.41%, while institutional ownership is 12.72%. The most recent insider transaction that took place on Oct 23 ’25, was worth 125,464. In this transaction Director of this company sold 154,894 shares at a rate of $0.81, taking the stock ownership to the 103,540 shares. Before that another transaction happened on Oct 22 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 32,230 for $0.83, making the entire transaction worth $26,751. This insider now owns 29,873 shares in total.
Kala Bio Inc (KALA) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.23 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -2.47) by 1.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 65.97% during the next five years compared to 40.66% growth over the previous five years of trading.
Kala Bio Inc (NASDAQ: KALA) Trading Performance Indicators
Check out the current performance indicators for Kala Bio Inc (KALA). In the past quarter, the stock posted a quick ratio of 0.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.94, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Kala Bio Inc (KALA)
The latest stats from [Kala Bio Inc, KALA] show that its last 5-days average volume of 75.01 million was superior to 2.15 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 24.70%.
During the past 100 days, Kala Bio Inc’s (KALA) raw stochastic average was set at 1.46%, which indicates a significant decrease from 22.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2248 in the past 14 days, which was lower than the 0.7234 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3812, while its 200-day Moving Average is $5.5318. Now, the first resistance to watch is $0.9941. This is followed by the second major resistance level at $1.0883. The third major resistance level sits at $1.1565. If the price goes on to break the first support level at $0.8317, it is likely to go to the next support level at $0.7635. The third support level lies at $0.6693 if the price breaches the second support level.
Kala Bio Inc (NASDAQ: KALA) Key Stats
There are currently 7,021K shares outstanding in the company with a market cap of 7.39 million. Presently, the company’s annual sales total 0 K according to its annual income of -38,510 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,560 K.
